145 related articles for article (PubMed ID: 1327064)
21. Aberrant expression of HLA-G antigen in interferon gamma-stimulated acute myelogenous leukaemia.
Mizuno S; Emi N; Kasai M; Ishitani A; Saito H
Br J Haematol; 2000 Oct; 111(1):280-2. PubMed ID: 11091213
[TBL] [Abstract][Full Text] [Related]
22. Application of flow cytometry to molecular medicine: detection of tumor necrosis factor-related apoptosis-inducing ligand receptors in acute myeloid leukaemia blasts.
Cappellini A; Mantovani I; Tazzari PL; Grafone T; Martinelli G; Cocco L; Martelli AM
Int J Mol Med; 2005 Dec; 16(6):1041-8. PubMed ID: 16273284
[TBL] [Abstract][Full Text] [Related]
23. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.
Estrov Z; Kurzrock R; Pocsik E; Pathak S; Kantarjian HM; Zipf TF; Harris D; Talpaz M; Aggarwal BB
J Exp Med; 1993 Mar; 177(3):763-74. PubMed ID: 8382256
[TBL] [Abstract][Full Text] [Related]
24. Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia.
Uckun FM; Fauci AS; Chandan-Langlie M; Myers DE; Ambrus JL
J Clin Invest; 1989 Nov; 84(5):1595-608. PubMed ID: 2681271
[TBL] [Abstract][Full Text] [Related]
25. c-Cbl tyrosine phosphorylation and subcellular localization in human primary leukemic cells.
Brizzi MF; Rosso A; Dentelli P; Ferrero D; Lanfrancone L; Pegoraro L
Exp Hematol; 1998 Dec; 26(13):1229-39. PubMed ID: 9845379
[TBL] [Abstract][Full Text] [Related]
26. Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage.
Kurzrock R; Kantarjian H; Wetzler M; Estrov Z; Estey E; Troutman-Worden K; Gutterman JU; Talpaz M
Exp Hematol; 1993 Jan; 21(1):80-5. PubMed ID: 8417962
[TBL] [Abstract][Full Text] [Related]
27. Receptors for tumor necrosis factor on neoplastic B cells from chronic lymphocytic leukemia are expressed in vitro but not in vivo.
Digel W; Schöniger W; Stefanic M; Janssen H; Buck C; Schmid M; Raghavachar A; Porzsolt F
Blood; 1990 Oct; 76(8):1607-13. PubMed ID: 2169926
[TBL] [Abstract][Full Text] [Related]
28. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs: the primary cause or a determinant of progression in leukemia?
Bousquet M; Lodish HF
Expert Rev Hematol; 2011 Apr; 4(2):121-3. PubMed ID: 21495919
[No Abstract] [Full Text] [Related]
30. Tumor necrosis factor as marker for monocyte function in chronic myeloid leukemia.
Chitnis VS; Parikh PM; Nadkarni JS; Kulkarni VC; Advani SH
Cancer Invest; 1996; 14(3):231-3. PubMed ID: 8630684
[TBL] [Abstract][Full Text] [Related]
31. bcr/abl mRNA in leukemic blasts of an unusual patient with acute lymphoblastic leukemia followed after 5-year remission by chronic myelogenous leukemia in blast crisis.
Fujie H; Tsuchiya S; Morita S; Itano M; Yambe T; Ohasi Y; Minegishi N; Minegishi M; Satou T; Konno T
Leukemia; 1994 Sep; 8(9):1592-5. PubMed ID: 8090037
[TBL] [Abstract][Full Text] [Related]
32. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of leukemia relapsed after allogenic bone marrow transplantation with donor lymphocyte infusion: report of 11 cases].
Sanz Rodríguez C; Steegmann JL; Granda A; de la Cámara R; Figuera A; Arranz R; Gómez-García de Soria V; Alegre A; Fernández-Rañada JM
Sangre (Barc); 1999 Dec; 44(6):456-63. PubMed ID: 10822760
[TBL] [Abstract][Full Text] [Related]
34. Chronic myelogenous leukaemia exosomes modulate bone marrow microenvironment through activation of epidermal growth factor receptor.
Corrado C; Saieva L; Raimondo S; Santoro A; De Leo G; Alessandro R
J Cell Mol Med; 2016 Oct; 20(10):1829-39. PubMed ID: 27196940
[TBL] [Abstract][Full Text] [Related]
35. [Expression of P27(Kip1) and its clinical significance in acute and chronic leukemia].
Lu RN; Sheng RL; Li JY; Zhu GR; Ding XJ; Zhu LL; Su EB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):291-7. PubMed ID: 15228653
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
Larsson LG; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
Leukemia; 1993 Feb; 7(2):226-34. PubMed ID: 8381194
[TBL] [Abstract][Full Text] [Related]
37. [Pathological features of neuroleukemia. Changes and lessons].
Garzuly F
Orv Hetil; 1994 Jun; 135(24):1291-5. PubMed ID: 8015823
[TBL] [Abstract][Full Text] [Related]
38. B-lineage lymphoid blast crisis in juvenile chronic myelogenous leukemia: II. Interleukin-1-mediated autocrine growth regulation of the lymphoblasts.
Attias D; Grunberger T; Vanek W; Estrov Z; Cohen A; Lau R; Freedman MH
Leukemia; 1995 May; 9(5):884-8. PubMed ID: 7769852
[TBL] [Abstract][Full Text] [Related]
39. Binding and crosslinking of 125I-labeled recombinant human tumor necrosis factor to cell surface receptors.
Yoshie O; Tada K; Ishida N
J Biochem; 1986 Sep; 100(3):531-41. PubMed ID: 3023310
[TBL] [Abstract][Full Text] [Related]
40. A morphological pattern of 234 cases of leukemias.
Hassan K; Ikram N; Shah SH
J Pak Med Assoc; 1994 Jun; 44(6):145-8. PubMed ID: 8089909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
